Últimas noticias sobre Vericel (NASDAQ:VCEL) Bolsa

Vericel

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Corp

Looking into the current session, Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) shares are trading at $331.17, after a 3.02% decrease. Over the past month, the stock decreased by 5.56%, but over the past year, it actually increased by 16.16%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1741716027_0.png" alt="Past Year Chart" />

<h3>Comparing Visa P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 101.89 in the Financial Services industry, Visa Inc. has a lower P/E ratio of 34.42. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1741716027_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

P/E Ratio Insights for Visa

In the last three months, 7 analysts have published ratings on CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CarMax, revealing an average target of $92.43, a high estimate of $105.00, and a low estimate of $72.00. Witnessing a positive shift, the current average has risen by 6.41% from the previous average price target of $86.86.
<img src="https://www.benzinga.com/files/images/story/2025/1741716027_0_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of CarMax's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$101.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$72.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$88.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$103.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Chris Pierce</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CarMax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of CarMax compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for CarMax's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into CarMax's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KMX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CarMax analyst ratings.</a>
<h2>Unveiling the Story Behind CarMax</h2>
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue (79% in fiscal 2024 due to the chip shortage) and wholesale about 13% (19% in fiscal 2024), with the remaining portion composed of extended service plans and repair. In fiscal 2024, the company retailed and wholesaled 765,572, and 546,331 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in 2023. It seeks over 5% share a few years from now. CarMax is based in Richmond, Virginia.
<h3>CarMax's Economic Impact: An Analysis</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: CarMax's remarkable performance in 3 months is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 1.22%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: CarMax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.02%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.02%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CarMax's ROA stands out, surpassing industry averages. With an impressive ROA of 0.46%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 3.09.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

7 Analysts Assess CarMax: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Crane, revealing an average target of $181.75, a high estimate of $200.00, and a low estimate of $157.00. This upward trend is evident, with the current average reflecting a 1.96% increase from the previous average price target of $178.25.
<img src="https://www.benzinga.com/files/images/story/2025/1741716019_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Crane among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$170.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$157.00</td>
<td>$152.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Crane. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Crane compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Crane's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Crane's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Crane analyst ratings.</a>
<h2>Delving into Crane's Background</h2>
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
<h3>Unraveling the Financial Story of Crane</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Crane's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.57% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Crane's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 20.9%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Crane's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 5.04%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Crane's ROA excels beyond industry benchmarks, reaching 3.06%. This signifies efficient management of assets and strong financial health.
Debt Management: Crane's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.19.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Crane Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Asana Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) stock plunged after multiple Wall Street firms cut their respective price targets.
Asana reported <a target="_blank" href="https://www.benzinga.com/25/03/44254322/asana-shares-are-tumbling-tuesday-whats-driving-the-action" rel="noreferrer noopener">fourth-quarter revenue</a> of $188.33 million, beating analyst estimates of $188.1 million. The company reported breakeven fourth-quarter earnings, beating analyst estimates for a loss of 1 cent per share.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44245291/ciena-q1-earnings-revenue-and-eps-beat-estimates-ceo-eyes-ai-cloud-network-tailwinds" rel="noreferrer noopener">Ciena Q1 Earnings: Revenue and EPS Beat Estimates, CEO Eyes AI, Cloud Network Tailwinds</a>
Asana guided for first-quarter revenue of $184.5 million-$186.5 million and first-quarter adjusted EPS of $0.02.
Asana co-founder, CEO, and chair&nbsp;Dustin Moskovitz&nbsp;informed the board of his intention to transition to chair. Asana has retained an executive search firm to search for a new CEO.
JP Morgan analyst Pinjalim Bora maintained Asana with an Underweight rating and lowered the <a target="_blank" href="https://www.benzinga.com/quote/ASAN/analyst-ratings" rel="noreferrer noopener">price target from&nbsp;$15&nbsp;to&nbsp;$13</a>.
The analyst writes that Asana&#8217;s fourth quarter highlighted the stabilization of growth and retention metrics while profitability outperformed. The fourth-quarter revenue aligned with consensus and marked a steady growth versus last quarter on an FX-adjusted basis.
Calculated billings landed slightly above, accelerating into the low-double-digit zone. Dollar-based net retention rate (DBNRR) was stable at 96% on a reported basis, while the in-quarter net retention rate improved sequentially.
While non-tech verticals were stable, Asana highlighted continued softness in the tech vertical (primarily driven by a reduction in seats and one logo churn).
This pressured the reported DBNRR for customers spending over $100K in ACV, which contracted 3 pts sequentially to 96%, landing in line with the overall reported number for the first time.
On AI studio, Asana reported that the early momentum had exceeded the company&#8217;s expectations. It has already amassed a multi-million dollar pipeline and paid customers.
As such, the company aims to establish a dedicated sales team to capitalize on the opportunity and embark on some broader sales capacity alignment.
The brightest spot in the results was a solid improvement in profitability in the quarter and in the guide.
While the company highlighted several avenues of conservatism in the guide (not baking in any improvement in net retention or performance of the tech vertical and baking in de minimis contribution from AI Studio, with no contribution from consumption), Bora&#8217;s understanding is that the guide was set a couple of weeks ago, and does not bake in any deterioration in macro from the current levels, which could be a risk to the plan (offset by potential improvement in FX during that period).
Overall, while growth continues to materially lag that of peers, which would likely drive underperformance in the shares in the near term. Bora noted Asana as essentially a profitability story from here on out, with multiple levers to drive material improvement in margins in the future.
Bora projected first-quarter revenue of $186 million and adjusted EPS of $0.02.
Price Action: ASAN stock is down 23.6% at $12.74 at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44235249/slowdown-and-tariff-talk-grips-the-hottest-sector-on-wall-street-semiconductor-etf-now-has-a-negative-1-year-return" target="_blank" rel="noreferrer noopener">Slowdown And Tariff Talk Grips The Hottest Sector On Wall Street &#8211; Semiconductor ETF Now Has A Negative 1-Year Return</a></li>
</ul>
Photo by FellowNeko via Shutterstock

Analyst Color

Price Target

Reiteration

Movers

Trading Ideas

ASAN

Asana Growth Materially Lags Peers, JP Morgan Cuts Price Forecast

WIIM

LAMR

Shares of real estate ETFs are trading lower following a rise in treasury yields, which can raise borrowing costs for firms and enhance the relative attractiveness of bonds for income-oriented investors.

Lake Street initiates coverage on Lakeland Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>) with a Buy rating and announces Price Target of $30.

Initiation

LAKE

Lake Street Initiates Coverage On Lakeland Industries with Buy Rating, Announces Price Target of $30

Biotech

General

MRNA

Moderna Exec Says Co Expects "Little Bit More Of A Business As Usual" In Terms Of Vaccine-Related Meetings As Confirmations For Key Healthcare Roles Take Place

Wall Street's losing streak extended into Tuesday, with stocks deepening their slump as continued trade war fears rattled investor sentiment. 
The Nasdaq 100 slipped 0.6% by midday trading in New York after suffering on Monday its worst single-day drop since September 2022<a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44255030/nasdaq-100-trades-below-its-200-day-moving-average-history-says-you-should-buy-the-dip-now"> in the prior session. </a>
The broader S&amp;P 500 slid to a seven-month low, amplifying concerns over the market's near-term trajectory.
The proportion of S&amp;P 500 stocks trading above their 200-day moving average has now shrunk to 44%, the lowest since November 2023. Each sector traded in the red, highlighting broad-based market weakness. 
The Dow Jones Industrial Average was the biggest underperformer on Tuesday, with industrial stocks bearing the brunt of escalating trade tensions.
On Tuesday, President Donald Trump escalated trade tensions by raising tariffs on Canadian steel and aluminum imports to 50%, responding to Ontario's move to levy a 25% tariff on <a href="https://www.benzinga.com/news/25/03/44253100/trump-slaps-50-tariff-on-canadian-steel-aluminum-threatens-auto-industry">electricity exports to the U.S. </a>
In a Truth Social post, Trump announced he had instructed the Commerce secretary to enforce the additional 25% tariff, which will take effect Wednesday morning.
On the macroeconomic front, job openings in the U.S. showed unexpected resilience, rising by 232,000 to 7.74 million in January from a downwardly revised 7.51 million in December. The reading exceeded market forecasts of 7.63 million, suggesting positive labor market news despite broader economic jitters.
The U.S. dollar continued its descent, with the dollar index slipping to six-month lows. Treasury yields edged higher ahead of Wednesday's closely watched inflation report for February, signaling that investors were not rushing into safe-haven bonds despite the ongoing market turbulence.
Commodities, meanwhile, found favor as investors sought inflation hedges. Gold advanced 1%, silver surged 2.3% and copper climbed 3%, reflecting renewed demand for tangible assets in a climate of heightened financial instability.
Bitcoin endured a wild session, initially plunging to an intraday low of $76,600 — its lowest level since Nov. 10, 2024 — before rebounding to post a 3.9% gain on the day.
<h1 class="wp-block-heading">Wednesday's Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg %</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,011.25</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,305.23</td>
<td>-0.6%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,552.25</td>
<td>-1.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,296.00</td>
<td>-1.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;fell 1.2% to $553.88.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 1.5% to $413.04.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.6% to $469.56.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.7% to $199.32.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) managed to contain losses, yet still down 0.9%; the&nbsp;Communication Services&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)&nbsp;was the worst sector performer, down 1.9%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
<ul>
<li>Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) fell 3.3% after missing both <a href="https://www.benzinga.com/news/earnings/earnings-misses/25/03/44255998/oracles-q3-falls-short-but-ai-demand-keep-long-term-outlook-strong-say-analysts">earnings and revenue estimates last quarter</a>.</li>
<li>Other stocks reacting to corporate earnings report included: Ferguson Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>)​, down 4.7%; Viking Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>)​, <a href="https://www.benzinga.com/news/earnings/25/03/44254442/viking-holdings-beats-on-q4-earnings-says-88-passenger-cruise-days-for-fy25-already-booked">down </a>6.4%; DICK&#8216;S Sporting Goods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>)​, down 5.8% and Ciena Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>)​, down 3.6%,</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) shares dropped 6.9% after the company acknowledged at a conference that the quarter has been &#8220;challenging from a competitive intensity standpoint.&#8221; Verizon expects first-quarter postpaid phone gross additions to remain flat or decline slightly compared<a href="https://www.benzinga.com/news/guidance/25/03/44250482/verizon-communications-stock-is-sliding-tuesday-heres-why"> to the same period last year</a>.</li>
<li>Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) <a href="https://www.benzinga.com/general/travel/25/03/44237055/delta-air-lines-cuts-q1-guidance-below-estimates-airline-stocks-fall">revised its first-quarter earnings-per-share guidance</a> downward to 30 cents to 50 cents from the previous 70 cents–$1 range. The airline also lowered its revenue growth forecast to 3%–4% from the earlier 7%–9% projection. Delta shares fell 8.5%.</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44255030/nasdaq-100-trades-below-its-200-day-moving-average-history-says-you-should-buy-the-dip-now">Nasdaq 100 Trades Below Its 200-Day Moving Average: History Says You Should Buy The Dip Now</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Global

Econ #s

Economics

Tech

ETFs

CIEN

SPDR Dow Jones Industrial Average ETF Trust

FERG

ORCL

Wall Street Drop Deepens As Trade War Fears Escalate, S&P 500 Hits 7-Month Lows: What's Driving Markets Tuesday?

Keefe, Bruyette &amp; Woods analyst Jade J. Rahmani downgraded Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) from Outperform to Market Perform and reduced <a target="_blank" href="https://www.benzinga.com/quote/LEN/analyst-ratings" rel="noreferrer noopener">the price forecast from $152 to $141.</a>
The analyst writes that the company&#8217;s valuation is now comparable to large-cap peers, with potential downside risks to estimates.
The analyst expects a challenging Spring selling season and growing risks to gross margin due to the tough macro environment and uncertainty <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43625476/lennar-completes-spin-off-of-millrose-properties" rel="noreferrer noopener">from the </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43625476/lennar-completes-spin-off-of-millrose-properties" rel="noreferrer noopener">Millrose Properties</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43625476/lennar-completes-spin-off-of-millrose-properties" rel="noreferrer noopener"> spin-off</a>.
Consequently, Rahmani stated that he had adopted a more cautious approach towards the company. The analyst moves to the sidelines and awaits a better entry point.
While the analyst still sees the company as well-positioned due to several factors, such as its low financial leverage, potential ROE upside from the Millrose spin-off, and capital efficiency initiatives, the current housing market presents significant challenges.
The analyst cut the 2025-2026 estimates by 3%-4% to $11.89 and $13.44.
Rahmani continues to see order growth of 3% &#8211; 7% for the period. Meanwhile, the analyst revised estimates for deliveries growth to 5% &#8211; 6% (vs. prior estimates of 5% &#8211; 7%), gross margin to be 20.0% &#8211; 20.3% (vs. 20.3% &#8211; 20.5% earlier), and SG&amp;A to 7.6% &#8211; 7.7% (vs. 7.6% prior).
Investors can gain exposure to the stock via&nbsp;iShares U.S. Home Construction ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITB#BATS">ITB</a>) and John Hancock Exchange-Traded Fund Trust John Hancock Fundamental All Cap Core ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHAC#NYSE">JHAC</a>).
Price Action: LEN shares are down 3.12% at $121.32 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44200622/lennar-kb-home-face-tougher-housing-market-goldman-sachs-cuts-forecast-amid-slowing-demand" target="_blank" rel="noreferrer noopener">Lennar &amp; KB Home Face Tougher Housing Market, Goldman Sachs Cuts Forecast Amid Slowing Demand</a></li>
</ul>
Photo via Shutterstock.

Large Cap

Downgrades

iShares Dow Jones US Homenstruction Index Fund

JHAC

Lenna Analyst Moves To Sidelines, Downgrades Stock And Awaits Better Entry Point

Mizuho analyst Ben Chaiken maintains Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) with a Outperform and lowers the price target from $227 to $215.

Mizuho Maintains Outperform on Vail Resorts, Lowers Price Target to $215

On Monday, Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) said that it is implementing cost cuts of approximately $100 million in fiscal year 2025 in response to China's recent ban on importing <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">its sequencers</a>.
Last week, China banned imports of genetic sequencers from&nbsp;Illumina just after U.S. President&nbsp;Donald Trump's&nbsp;additional 10% tariff on Chinese goods took effect.
China accounted&nbsp;for&nbsp;about 7% of Illumina's&nbsp;sales of <a target="_blank" href="https://www.benzinga.com/general/health-care/25/03/44110625/us-firm-illumina-faces-setback-as-china-blocks-imports-amid-escalating-trade-war" rel="noreferrer noopener">$4.3 billion&nbsp;in 2024</a>.
The diagnostic firm has lowered its 2025 adjusted EPS guidance to $4.50, at the low end of the range of $4.50 to $4.65, compared to the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43544682/illumina-reports-financial-results-for-fourth-quarter-and-fiscal-year-2024" rel="noreferrer noopener">consensus of $4.45</a>.
In February, the Chinese Ministry of Commerce added Illumina and Calvin Klein owner&nbsp;PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) to its list of unreliable entities amid the ongoing&nbsp;<a target="_blank" href="https://www.benzinga.com/news/events/25/02/43455326/illumina-stock-tumbles-nearly-5-overnight-on-robinhood-as-china-adds-ilmn-calvin-klein-owner-pvh-to-u" rel="noreferrer noopener">trade war with the U.S</a>.
China claimed the two companies had disrupted normal market transactions and tried to harm the legitimate rights and interests of Chinese enterprises.
According to Illumina, "These savings would mitigate the impact of a range of potential scenarios for a reduction in revenue and related operating income from the company's Greater China business. The cost reduction program includes optimizing stock-based compensation and non-labor spending and accelerating certain productivity measures."
"Our new fiscal 2025 guidance provides for limited further earnings contribution from China and assumes a continuation of the macro trends we see today," Illumina CFO Ankur Dhingra <a target="_blank" href="https://www.benzinga.com/secfilings/25/03/44236048/illumina-inc-general-corporate-statement-form8" rel="noreferrer noopener">said</a> in a statement.
"We will continue to invest in our growth strategy, while taking actions to achieve EPS of approximately $4.50 in 2025, and then grow from there." "We remain focused on achieving high-single-digit revenue growth by 2027, while expanding our margins," Illumina CEO Jacob Thaysen said in a statement.
Illumina CFO Dhingra <a target="_blank" href="https://www.wsj.com/world/china/illumina-to-cut-100-million-in-costs-lowers-guidance-because-of-china-sales-ban-ff8b495a?mod=latest_headlines" rel="noreferrer noopener">told</a> the Wall Street Journal that the company still runs a facility in China that assembles its older machines. Illumina will also continue selling chemicals and other services to Chinese customers. According to Dhingra, about 90% of the company's global revenue comes from these chemical and service sales.
Price Action: ILMN stock is down 1.24% at $84.90 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44251890/fuelcell-energy-reports-q1-miss-highlights-lower-losses-and-positive-momentum-from-global-restructuring-plan" target="_blank" rel="noreferrer noopener">FuelCell Energy Reports Q1 Miss, Highlights Lower Losses And Positive Momentum From Global Restructuring Plan</a></li>
</ul>
Photo via Shutterstock

Guidance

Health Care

Media

ILMN

Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions

Keefe, Bruyette &amp; Woods analyst Edward Firth downgrades Lloyds Banking Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYG#NYSE">LYG</a>) from Outperform to Market Perform.

Keefe, Bruyette & Woods Downgrades Lloyds Banking Group to Market Perform

Whales with a lot of money to spend have taken a noticeably bullish stance on Nu Holdings.
Looking at options history for Nu Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $506,319 and 8, calls, for a total amount of $383,350.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $11.0 to $15.0 for Nu Holdings over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Nu Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Nu Holdings's substantial trades, within a strike price spectrum from $11.0 to $15.0 over the preceding 30 days.
<h3>Nu Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741715161_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.0</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$15.00</td>
<td>$143.5K</td>
<td>13.7K</td>
<td>296</td>
</tr>
<tr>
<td>NU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$4.0</td>
<td>$3.85</td>
<td>$3.85</td>
<td>$14.00</td>
<td>$115.5K</td>
<td>164</td>
<td>300</td>
</tr>
<tr>
<td>NU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$3.15</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$13.00</td>
<td>$90.0K</td>
<td>255</td>
<td>300</td>
</tr>
<tr>
<td>NU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$0.39</td>
<td>$0.37</td>
<td>$0.37</td>
<td>$12.00</td>
<td>$61.7K</td>
<td>11.8K</td>
<td>1.8K</td>
</tr>
<tr>
<td>NU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.6</td>
<td>$0.56</td>
<td>$0.6</td>
<td>$12.00</td>
<td>$60.0K</td>
<td>443</td>
<td>3.0K</td>
</tr>
</tbody>
</table>

<h3>About Nu Holdings</h3>
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.
<h3>Current Position of Nu Holdings</h3>
<ul>
<li>With a volume of 29,518,118, the price of NU is up 2.17% at $10.34. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 63 days.</li>
</ul>
<h3>Expert Opinions on Nu Holdings</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $14.67.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Neutral rating on Nu Holdings with a target price of $14. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Nu Holdings, targeting a price of $15. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Nu Holdings with a target price of $15. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Nu Holdings, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

This Is What Whales Are Betting On Nu Holdings

Financial giants have made a conspicuous bearish move on Ford Motor. Our analysis of options history for Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) revealed 8 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $350,682, and 2 were calls, valued at $132,630.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.85 and $9.85 for Ford Motor, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Ford Motor's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Ford Motor's whale activity within a strike price range from $7.85 to $9.85 in the last 30 days. 
<h3>Ford Motor Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741715156_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>F</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.63</td>
<td>$1.51</td>
<td>$1.53</td>
<td>$9.85</td>
<td>$107.1K</td>
<td>12.1K</td>
<td>830</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$0.2</td>
<td>$0.19</td>
<td>$0.19</td>
<td>$9.85</td>
<td>$100.7K</td>
<td>7.5K</td>
<td>6.7K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.82</td>
<td>$0.81</td>
<td>$0.82</td>
<td>$9.67</td>
<td>$100.4K</td>
<td>56.7K</td>
<td>3.5K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1.31</td>
<td>$1.28</td>
<td>$1.31</td>
<td>$9.67</td>
<td>$47.9K</td>
<td>37.6K</td>
<td>1.3K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.81</td>
<td>$0.8</td>
<td>$0.81</td>
<td>$9.67</td>
<td>$36.8K</td>
<td>56.7K</td>
<td>1.7K</td>
</tr>
</tbody>
</table>

<h3>About Ford Motor</h3>
Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022, the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor. The company has nearly 13% market share in the United States, about 10% share in the UK, and under 2% share in China including unconsolidated affiliates. Sales in the US made up about 68% of 2024 total company revenue. Ford has about 171,000 employees, including about 56,500 UAW employees, and is based in Dearborn, Michigan.
After a thorough review of the options trading surrounding Ford Motor, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Ford Motor's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 131,225,490, the F's price is down by -4.47%, now at $9.52. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
<h3>Expert Opinions on Ford Motor</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $10.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a In-Line rating on Ford Motor with a target price of $10. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Ford Motor with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On Ford Motor

Financial giants have made a conspicuous bearish move on Roku. Our analysis of options history for Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) revealed 18 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $983,048, and 7 were calls, valued at $692,635.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $80.0 for Roku over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Roku's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Roku's significant trades, within a strike price range of $50.0 to $80.0, over the past month.
<h3>Roku Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741715151_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.65</td>
<td>$71.00</td>
<td>$269.7K</td>
<td>805</td>
<td align="right">587</td>
</tr>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.6</td>
<td>$5.25</td>
<td>$5.5</td>
<td>$50.00</td>
<td>$259.6K</td>
<td>12.1K</td>
<td align="right">477</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$9.0</td>
<td>$8.95</td>
<td>$9.0</td>
<td>$70.00</td>
<td>$236.7K</td>
<td>1.2K</td>
<td align="right">576</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.95</td>
<td>$8.95</td>
<td>$8.95</td>
<td>$70.00</td>
<td>$196.0K</td>
<td>1.2K</td>
<td align="right">795</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.05</td>
<td>$8.9</td>
<td>$8.9</td>
<td>$70.00</td>
<td>$95.2K</td>
<td>1.2K</td>
<td align="right">902</td>
</tr>
</tbody>
</table>

<h3>About Roku</h3>
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.
Following our analysis of the options activities associated with Roku, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Roku</h3>
<ul>
<li>Currently trading with a volume of 1,538,178, the ROKU's price is down by -3.58%, now at $68.6. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 44 days.</li>
</ul>
<h3>What Analysts Are Saying About Roku</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $109.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies has elevated its stance to Hold, setting a new price target at $100. 
&#x2A; Showing optimism, an analyst from Wells Fargo upgrades its rating to Overweight with a revised price target of $129. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Roku, targeting a price of $115. 
&#x2A; An analyst from JMP Securities persists with their Market Outperform rating on Roku, maintaining a target price of $115. 
&#x2A; An analyst from Rosenblatt persists with their Neutral rating on Roku, maintaining a target price of $86. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Roku with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

ROKU

Roku Options Trading: A Deep Dive into Market Sentiment

Airbnb Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) shares are trading lower by 6.2% to $123.87 during Tuesday&#8217;s session. Shares of several travel-related stocks fell Tuesday following Delta Air Lines Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) <a href="https://www.benzinga.com/general/travel/25/03/44237055/delta-air-lines-cuts-q1-guidance-below-estimates-airline-stocks-fall">announcement</a> of lowered revenue and profit guidance, which raised concerns about weakening travel demand. Additionally, American Airlines Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) cut its first-quarter adjusted EPS outlook.
What To Know: Delta and American Airlines&#8217; revised forecasts, citing economic uncertainty and declining consumer confidence, signals a potential slowdown in discretionary spending, a key driver for Airbnb&#8217;s short-term rental business.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/03/44246040/kohls-anticipates-sales-and-profit-dip-in-2025-slashes-dividend-by-75-stock-tanks">Kohl&#8217;s Anticipates Sales And Profit Dip In 2025, Slashes Dividend By 75%, Stock Tanks</a>
Airbnb heavily relies on strong travel demand, particularly in the domestic U.S. market, where Delta flagged softness. If consumers are cutting back on flights due to financial concerns, they may also reduce spending on accommodations, directly impacting Airbnb&#8217;s bookings. 
Additionally, Delta's CEO noted declines in both corporate and leisure travel, suggesting a broader pullback that could weigh on Airbnb's revenue growth.
With travel demand appearing weaker than expected, investors fear Airbnb's outlook may also soften. The company's dependence on resilient travel trends makes it particularly vulnerable to shifts in consumer sentiment.
Read Also: <a href="https://www.benzinga.com/25/03/44246635/traders-brace-for-pivotal-february-inflation-data-as-stagflation-fears-weigh-on-wall-street-what-to-expect">Traders Await Pivotal February Inflation Data As Stagflation Fears Weigh On Wall Street: What To Expect</a>
<h2 class="wp-block-heading">How To Buy ABNB Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Airbnb&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ABNB has a 52-week high of $170.10 and a 52-week low of $110.38.

ABNB

What's Going On With Airbnb (ABNB) Shares?

AgriFORCE Growing Systems Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGRI#NASDAQ">AGRI</a>), a leading technology-driven innovator, today announced significant progress in its Radical Clean Solutions (RCS) division, acquired in August 2024.
The RCS division has been awarded a U.S.&nbsp;patent&nbsp;(Patent No. 17/713,959), dated today, for its design of agricultural integrated systems for Radicals Hydroxyl generation units. This innovative technology provides growers of fruits, vegetables, and other plants with a chemical-free solution for reducing mold, viruses, and volatile organic compounds (VOCs). It can be integrated into existing heating and ventilation systems or used as a standalone unit. Additionally, the system helps lower levels of gases such as ethylene, thereby slowing the ripening process and extending the shelf life of produce.

AGRI

AgriFORCE Growing Systems Announces U.S. Patent For RCS Division's Radical Hydroxyl Generation Tech, Providing Chemical-Free Solution To Reduce Mold, Viruses, VOCs, And Ethylene, Extending Produce Shelf Life

– Phase 1 Data Indicate Potential for Use of Once-Yearly Lenacapavir for HIV Prevention, with Plans to Launch a Phase 3 Trial in 2H 2025 –
– Also at CROI: New PURPOSE 1 Data Showcasing Preference for Twice-Yearly Lenacapavir vs. Once-Daily Orals and In-Depth Look at Adolescent Pharmacokinetic, Safety and Efficacy Data –
Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company's injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention as pre-exposure prophylaxis (PrEP). The data were presented during an oral abstract session at the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.croiconference.org%2F&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=Conference+on+Retroviruses+and+Opportunistic+Infections+%28CROI+2025%29&amp;index=1&amp;md5=0fafdb2afddbf29a67a862e132e0e488">Conference on Retroviruses and Opportunistic Infections (CROI 2025)</a> and were also published today in <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%252825%252900405-2%2Ffulltext&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=The+Lancet&amp;index=2&amp;md5=c3f2c8a6aa1342e85f0988ce3b22c75b">The Lancet</a>. Data will support the future development of once-yearly lenacapavir for PrEP, for which Gilead plans to launch a Phase 3 study in the second half of 2025.
The Phase 1 study data showed that the two different formulations of once-yearly lenacapavir administered via intramuscular injection achieved and maintained plasma concentrations exceeding those associated with HIV prevention efficacy observed in the Phase 3 <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gilead.com%2Fnews%2Fnews-details%2F2024%2Ffull-efficacy-and-safety-results-for-gilead-investigational-twice-yearly-lenacapavir-for-hiv-prevention-presented-at-aids-2024&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=PURPOSE+1+trial&amp;index=3&amp;md5=fae50b34fe3d1937f06ea61a224ce2e6">PURPOSE 1 trial</a> (<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT04994509&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=NCT04994509&amp;index=4&amp;md5=9628ecf3bbd99007a00874c89ce08c7d">NCT04994509</a>) and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gilead.com%2Fnews%2Fnews-details%2F2024%2Fgilead-presents-full-purpose-2-data-results-for-twice-yearly-lenacapavir-for-hiv-prevention-at-hiv-glasgow&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=PURPOSE+2+trial&amp;index=5&amp;md5=e858a579f72e1e91233fc2a994376bef">PURPOSE 2 trial</a> (<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT04925752%3Fcond%3DHIV%26term%3Dpurpose%25202%26rank%3D1&amp;esheet=54222447&amp;newsitemid=20250311300348&amp;lan=en-US&amp;anchor=NCT04925752&amp;index=6&amp;md5=d78f50b34977573acad0d5f355c25638">NCT04925752</a>). The previously reported PURPOSE 1 and PURPOSE 2 data showed that twice-yearly subcutaneous lenacapavir demonstrated superiority at reducing HIV infections when compared to background HIV incidence (bHIV) and once-daily oral Truvada&#xAE; (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) in a broad and geographically diverse range of people.

GILD

Gilead Sciences Presented First Clinical Data For Its Investigational Once-Yearly Lenacapavir For HIV Prevention At CROI 2025 And Published In The Lancet

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$35.00</td>
<td>$43.0K</td>
<td>680</td>
<td>1.7K</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/14/25</td>
<td>$815.00</td>
<td>$26.5K</td>
<td>38</td>
<td>268</td>
</tr>
<tr>
<td>BMY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$62.50</td>
<td>$125.9K</td>
<td>90</td>
<td>253</td>
</tr>
<tr>
<td>SYK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$360.00</td>
<td>$119.2K</td>
<td>472</td>
<td>203</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$210.00</td>
<td>$95.5K</td>
<td>290</td>
<td>193</td>
</tr>
<tr>
<td>IQV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$180.00</td>
<td>$200.2K</td>
<td>31</td>
<td>111</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$490.00</td>
<td>$99.7K</td>
<td>92</td>
<td>77</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$165.00</td>
<td>$26.6K</td>
<td>6.1K</td>
<td>56</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$330.00</td>
<td>$80.8K</td>
<td>14</td>
<td>29</td>
</tr>
<tr>
<td>TMO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$600.00</td>
<td>$101.9K</td>
<td>0</td>
<td>10</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For VKTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), we notice a call option trade that happens to be bullish, expiring in 37 day(s) on April 17, 2025. This event was a transfer of 426 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $43.0K, with a price of $101.0 per contract. There were 680 open contracts at this strike prior to today, and today 1750 contract(s) were bought and sold. 
• For LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we notice a call option trade that happens to be neutral, expiring in 3 day(s) on March 14, 2025. This event was a transfer of 20 contract(s) at a $815.00 strike. The total cost received by the writing party (or parties) was $26.5K, with a price of $1325.0 per contract. There were 38 open contracts at this strike prior to today, and today 268 contract(s) were bought and sold. 
• For BMY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), we notice a put option sweep that happens to be bearish, expiring in 192 day(s) on September 19, 2025. This event was a transfer of 221 contract(s) at a $62.50 strike. This particular put needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $125.9K, with a price of $570.0 per contract. There were 90 open contracts at this strike prior to today, and today 253 contract(s) were bought and sold. 
• For SYK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), we notice a put option trade that happens to be bearish, expiring in 10 day(s) on March 21, 2025. This event was a transfer of 200 contract(s) at a $360.00 strike. The total cost received by the writing party (or parties) was $119.2K, with a price of $596.0 per contract. There were 472 open contracts at this strike prior to today, and today 203 contract(s) were bought and sold. 
• For ABBV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), we notice a put option sweep that happens to be bullish, expiring in 31 day(s) on April 11, 2025. This event was a transfer of 193 contract(s) at a $210.00 strike. This particular put needed to be split into 16 different trades to become filled. The total cost received by the writing party (or parties) was $95.5K, with a price of $495.0 per contract. There were 290 open contracts at this strike prior to today, and today 193 contract(s) were bought and sold. 
• Regarding IQV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>), we observe a put option sweep with bullish sentiment. It expires in 283 day(s) on December 19, 2025. Parties traded 110 contract(s) at a $180.00 strike. This particular put needed to be split into 24 different trades to become filled. The total cost received by the writing party (or parties) was $200.2K, with a price of $1820.0 per contract. There were 31 open contracts at this strike prior to today, and today 111 contract(s) were bought and sold. 
• For UNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), we notice a put option trade that happens to be bullish, expiring in 192 day(s) on September 19, 2025. This event was a transfer of 23 contract(s) at a $490.00 strike. The total cost received by the writing party (or parties) was $99.7K, with a price of $4335.0 per contract. There were 92 open contracts at this strike prior to today, and today 77 contract(s) were bought and sold. 
• Regarding JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we observe a call option trade with bullish sentiment. It expires in 101 day(s) on June 20, 2025. Parties traded 35 contract(s) at a $165.00 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $760.0 per contract. There were 6139 open contracts at this strike prior to today, and today 56 contract(s) were bought and sold. 
• For CI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), we notice a put option trade that happens to be bullish, expiring in 192 day(s) on September 19, 2025. This event was a transfer of 26 contract(s) at a $330.00 strike. The total cost received by the writing party (or parties) was $80.8K, with a price of $3110.0 per contract. There were 14 open contracts at this strike prior to today, and today 29 contract(s) were bought and sold. 
• Regarding TMO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), we observe a put option trade with neutral sentiment. It expires in 464 day(s) on June 18, 2026. Parties traded 10 contract(s) at a $600.00 strike. The total cost received by the writing party (or parties) was $101.9K, with a price of $10193.0 per contract. There were 0 open contracts at this strike prior to today, and today 10 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABBV

VKTX

10 Health Care Stocks Whale Activity In Today's Session

Politics

Ontario Energy Minister Says We Cannot Accept This Interruption In Free Flow Of Goods With U.S.; Hopes U.S. And Canada Can Use Off-Ramp Of USMCA Renegotiation To End Dispute

Comments

Vericel

Noticias

Últimas noticias sobre Vericel (NASDAQ:VCEL) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL